UTHR United Therapeutics Corporation
NewsSee all news
-
CollPlant Reports Third Quarter 2019 Financial Results and Provides Business Update
REHOVOT, Israel, Nov. 29, 2019 /PRNewswire/ -- CollPlant (NASDAQ:CLGN), a regenerative medicine company, today announced financial results for the third quarter ended September 30, 2019 and provided an update on the
-
Correvio Reports Third Quarter 2019 Financial Results
NASDAQ: CORV TSX: CORV FDA Accepts Brinavess™ New Drug Application Advisory Committee Date Set for December 10, 2019 PDUFA Date Set for December 24, 2019 Management to Host Conference Call and Webcast Today, November
-
United Therapeutics Corporation Reports Third Quarter 2019 Financial Results
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2019 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ:UTHR) today announced its financial results for the quarter ended September 30, 2019. "We are
-
United Therapeutics Corporation to Report Third Quarter 2019 Financial Results Before the Market Opens on Wednesday, October 30, 2019
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 23, 2019 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ:UTHR) announced today that it will report its third quarter 2019 financial results before the
-
United Therapeutics Announces FDA Approval Of Updated Label For Orenitram Reflecting Results Of FREEDOM-EV Study
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2019 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ:UTHR) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplement
Drug Information
Drug catalyst information is displayed when you hover over / tap on the stage bar graph.
Latest News
-
CollPlant Reports Third Quarter 2019 Financial Results and Provides Business Update
REHOVOT, Israel, Nov. 29, 2019 /PRNewswire/ -- CollPlant (NASDAQ:CLGN), a regenerative medicine company, today announced financial results for the third quarter ended September 30, 2019 and provided an update on the
-
Correvio Reports Third Quarter 2019 Financial Results
NASDAQ: CORV TSX: CORV FDA Accepts Brinavess™ New Drug Application Advisory Committee Date Set for December 10, 2019 PDUFA Date Set for December 24, 2019 Management to Host Conference Call and Webcast Today, November
-
United Therapeutics Corporation Reports Third Quarter 2019 Financial Results
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2019 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ:UTHR) today announced its financial results for the quarter ended September 30, 2019. "We are
-
United Therapeutics Corporation to Report Third Quarter 2019 Financial Results Before the Market Opens on Wednesday, October 30, 2019
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 23, 2019 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ:UTHR) announced today that it will report its third quarter 2019 financial results before the
-
United Therapeutics Announces FDA Approval Of Updated Label For Orenitram Reflecting Results Of FREEDOM-EV Study
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2019 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ:UTHR) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplement
-
Respira Therapeutics Regains North America Rights from United Therapeutics to Phase 2 Inhaled Drug-Device Product, RT234, for Pulmonary Hypertension Indications
ALBUQUERQUE, N.M., Oct. 10, 2019 /PRNewswire/ -- Respira Therapeutics, a clinical-stage specialty pharmaceutical company developing next-generation cardiopulmonary disease-targeted inhalation products, has regained full
-
United Therapeutics Announces FDA Acceptance Of Trevyent New Drug Application For Review
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Sept. 11, 2019 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ:UTHR) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review